China Dasheng Biotechnology (CDBT) Short Interest Ratio & Short Volume

Short interest is the volume of China Dasheng Biotechnology shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 100 shares of CDBT short. 0.00% of China Dasheng Biotechnology's shares are currently sold short. Learn More on China Dasheng Biotechnology's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of China Dasheng Biotechnology's floating shares are currently sold short.

0.00% of China Dasheng Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "retail" compare to China Dasheng Biotechnology: Yunji Inc. (0.67%), Digital Brands Group, Inc. (1.47%), Webuy Global Ltd (0.84%), Lazydays Holdings, Inc. (0.08%), Jowell Global Ltd. (1.39%), Linkage Global Inc (1.77%), American Sierra Gold Corp. (0.00%), Jeffs' Brands Ltd (27.44%), LMP Automotive Holdings, Inc. (0.01%), Kaixin Holdings (2.90%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), Strategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

Short selling CDBT is an investing strategy that aims to generate trading profit from China Dasheng Biotechnology as its price is falling. CDBT shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for China Dasheng Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CDBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDBT, twice per month. The most recent reporting period available is March, 15 2025.